RebeccaLeighKingMD

PubMed

• Transformation in marginal zone lymphoma: results from a prospective cohort and a meta-analysis of the literature.
  Côme Bommier, Brian K Link, Brianna J Gysbers, Matthew J Maurer, Melissa C Larson
  Blood Advances. 2024-12-10
• Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation.
  Matthew E Stokes, Kerstin Wenzl, C Chris Huang, María Ortiz, Chih-Chao Hsu
  Nature Communications. 2024-08-08
• Incidence of Central Nervous System Relapse in Primary Mediastinal Large B-Cell Lymphoma: Implications for Central Nervous System Prophylaxis.
  Izel Okcu, Yucai Wang, Allison M Bock, Jihao Zhou, Muhamad Alhaj Moustafa
  Clinical Lymphoma, Myeloma & Leukemia. 2024-08-02

Abstracts/Posters

• Clinical Features and Treatment for Neurolymphomatosis in the Rituximab Era: Single Institution Experience
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Event-Free Survival at 24 Months Following Autologous Stem Cell Transplant in Diffuse Large B-Cell Lymphoma
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Response to Erythropoiesis Stimulating Agents in Patients with WHO-Defined Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytos...
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Immunoglobulin Variable Gene Region (IGVL) Usage Correlates with Distinct Clinical Presentation in IgM Versus Non-IgM Light Chain Amyloidosis
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Clustering of Transcriptomic Signatures in Newly Diagnosed Diffuse Large B-Cell Lymphoma Identifies Two High-Risk Subgroups Which Increase in Prevalence at Relapse
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Genomic Analysis of R2CHOP-Treated DLBCL Reveals a High-Risk Population Driven By Inflammatory Pathways
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Genomic Landscape Including Novel Mutational Drivers in Relapsed/Refractory Diffuse Large B Cell Lymphoma
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Waldenstr_m Macroglobulinemia with Excess Plasma Cells: Is It a Distinct Entity?
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Potential Factors That Impact Lenalidomide/R-CHOP Efficacy in Previously Untreated Diffuse Large B-Cell Lymphoma in the ROBUST and ECOG-ACRIN 1412 Studies
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all